Portfolio Companies 2026 for Invus: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Invus accounts for 49 tracked companies with verified cap-table data, 49 of which disclose round sizes totalling $14B. The median disclosed raise is $194M, and the largest is Morphic Therapeutic at $3.2B, ahead of Moderna Therapeutics ($650M) and Mirador Therapeutics ($650M).
The names that recur most often on these portfolio cap tables are Invus (49 companies), RA Capital Management (9 companies), Janus Henderson Investors (9 companies), Redmile Group (7 companies), Alexandria Venture Investments (7 companies), Polaris Partners (6 companies). By latest disclosed round, the market skews Series B (17), Series C (11), Series A (10), Series D (3).
Companies tracked: 49
Disclosed funding total: $14B across 49 companies
Median disclosed raise: $194M
Largest raise: Morphic Therapeutic — $3.2B
Stage mix: Series B 17 · Series C 11 · Series A 10 · Series D 3
